N/A
Completed N=100
Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis
Source: ClinicalTrials.gov NCT01238848 ↗Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Aug 2012
Primary outcomePrimary: Hospitalization Days — 5.8; 5.47 days
Summary
The purpose of this study is to evaluate the efficacy of hypertonic saline vs. normal saline in the treatment of infants hospitalized for bronchiolitis, regarding length of hospital stay, oxygen requirements and clinical outcome.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Hospitalization Days |
5.8; 5.47 | — |
| SECONDARY Length of Oxygen Use |
4; 3.22 | — |
Eligibility Criteria
Inclusion criteria
- Infants aged 1 to 24 months, hospitalized for first episode of bronchiolitis, with severity score ≥ 5 points and oxygen saturation ≥ 97%.
Exclusion Criteria
- Chronic respiratory or cardiovascular disease, respiratory failure.
Data sourced from ClinicalTrials.gov (NCT01238848). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.